1.
Journal of Clinical Laboratory [The]. 2010; 5 (9): 18-28
em Árabe
| IMEMR
| ID: emr-126501
RESUMO
Beta 2-Glycoprotein I [beta 2-GPI], a plasma protein with in vitro anticoagulant properties, has been recognized to have an important role in the antiphospholipid syndrome [APS] as a cofactor and an [co]antigen. Recent study showed that Anti-beta2- GPI antibodies were found in the immunoassays of patients with defined antiphospholipid syndrome, but also in patients with thromboembolic pulmonary hypertension, cerebral infarction, and coronary heart disease. The study comprised 76 subjects [48 patients with myocardial infarction and 28 controls], anti-beta2-GP1 IgG were detected using immunoassay. Anti-beta2- GPI IgG antibodies, seemed to behave as independent risk factor for myocardial infarction